CLOs on the Move

Fastsigns

www.fastsigns.com

 
Fastsigns is a signage, graphics and visual communications partner that provides comprehensive solutions to help customers of all sizes--across all industries--meet their business objectives and increase their business visibility through the use of signs, graphics, printing, promotional products and related marketing services. The almost 700 centers worldwide provide consulting, design, production, project management, delivery and installation. Centers are independently owned and operated. FASTSIGNS operates in the United States (including Puerto Rico), Canada, the United Kingdom, the Caribbean, Mexico, Saudi Arabia, Chile and the UAE. In Australia, centers operate under the name SIGNWAVE®.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Alfred Robbins Realty Group

Alfred Robbins Realty Group is a specialized real estate brokerage dedicated to serving Naples most exclusive properties.

Mid-america Paper Recycling Co.

Mid-america Paper Recycling Co., Inc is a Chicago, IL-based company in the Business Services sector.

automated control engineers

automated control engineers is a Jacksonville, FL-based company in the Business Services sector.

Illinois House Medic

Illinois House Medic is a Downers Grove, IL-based company in the Business Services sector.

RxStrategies

Established in 2003 and headquartered in Boca Raton, Florida, RxStrategies, Inc. provides accountability, transparency and value-based solutions for the Federal 340B Drug Pricing Programs. As a full-service 340B Drug Pricing Program services organization, RxStrategies provides a diverse range of services to all “Qualified Entities” and the in-house and/or contract pharmacies, including 340B administration, split billing, orphan drug, and audit services. RxStrategies` “real-time” comprehensive solutions are designed to meet the challenges of regulatory compliance, patient eligibility, pharmacy replenishment, program tracking and reporting of the Federal 340B Drug Pricing Program.